U.S. COMPANY FILING
Edwards Lifesciences Corp — Form 10-Q filed 2026-05-06
Filing text preview
Edwards Lifesciences reported Q1 2026 net sales of $1,648.6 million, up 17% year-over-year, and net income of $380.7 million, up 7%. The company acquired Autus Valve Technologies, recognized a $123.6 million impairment loss, and faces IRS transfer pricing adjustments.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record